How C. difficile bacteria wreak havoc in guts
In a new paper in the journal Infection and Immunity, the researchers lay out for the first time exactly how C. difficile wreaks havoc on the guts of animals in a… read more.
In a new paper in the journal Infection and Immunity, the researchers lay out for the first time exactly how C. difficile wreaks havoc on the guts of animals in a… read more.
by Bruce Sylvester: Treatment with the growth hormone growth factor-1 (IGF-1) significantly improves social impairment associated with autism spectrum disorder (ASD) in patients with a related genetic syndrome,… read more.
by Bruce Sylvester: Results from a French pilot study suggest that gallopamil effectively reduces symptoms in severe asthma. The findings appeared on January 28, 2015 in the American Journal… read more.
Researchers have found a possible clue to why older mothers face a higher risk for having babies born with conditions such as Down syndrome that are characterized by abnormal… read more.
by Bruce Sylvester: Lenvatinib treatment has resulted in significant improvement in progression-free survival among patients with advanced radioiodine-refractory thyroid cancer, researchers from a Phase III trial reported in… read more.
by Gary Finnegan: Researchers in Canada have found that the chance having a heart attack or stroke increases significantly if a patient has been hospitalised for pneumonia –… read more.
by Gary Finnegan: The number of new medicines for rare diseases approved by EU drug regulators hit a record high in 2014. Of the 82 medicines given the… read more.
by Gary Finnegan: The European Medicines Agency (EMA) is to step up international cooperation on regulating generics. The regulator says it is ready to share assessment reports for… read more.
by Gary Finnegan: An electronic repository for periodic safety update reports (PSURs) and their assessment reports has been launched by the European Medicines Agency (EMA).
by Gary Finnegan: Seven new medicines have approved at the January meeting of the Committee for Medicinal Products for Human Use (CHMP) – the European Medicines Agency’s influential… read more.
by Bruce Sylvester: About 12 percent of patients treated with aspirin for cardiovascular disease prevention are receiving aspirin inappropriately, researchers reported on Jan, 12, 2015 in the Journal… read more.
by Bruce Sylvester: In the non-cardiac surgical setting, neither aspirin nor clonidine taken perioperatively appears to reduce the risk of acute kidney injury, researchers reported on Nov. 15,… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.